Gulden debutes the Rowe OCT Model Eye

Article

Gulden Ophthalmics recently introduced Rowe OCT Model Eye, a solid-state tissue phantom that is used by clamping it to an instrument and initiating an OCT test.

Elkins Park, PA-Gulden Ophthalmics recently introduced Rowe OCT Model Eye, a solid-state tissue phantom that is used by clamping it to an instrument and initiating an OCT test. It eliminates the need to use staff members or patients to check, practice, and use OCT equipment. Because it produces a standard test result based on a normal macula it provides a stabile, long-term benchmark for OCT instruments.

Imaging a choroidal nevus

According to the company, OCT Model Eye can be used for system demonstrations and tests; staff education, instruction, and practice; OCT instrument research and development; and as a standard for multi-instrument DME trials at several sites.            

The OCT Model Eye features a realistic, six-layer retina 300 um thick, 4.8 mm in diameter; a 120 um deep foveal pit; photoreceptor inner segment (IS)/outer segment (OS)/retinal pigment epithelium (RPE) layer with choroidal transition. It is fluid free and easy to image with a large 12.6 mm cornea and 8 mm diameter pupil and is 23.5 mm in axial length.  Images using the OCT Model Eye exhibit clear layer structure, foveal pit, and IS/OS/RPE layer.

The OCT Model Eye is provided and stored in a wooden case with instructions, an attachment rod for mounting on an ophthalmic instrument chin rest, and a mounting clamp.

Laser injury requires second opinion

Recent Videos
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Steve Ferrucci, OD, FAAO, discussed the detection and treatment of geographic atrophy during his AAOpt 2024 lecture, "Imaging Techniques and Emerging Therapies for Geographic Atrophy."
Raman Bhakhri, OD, FAAO, details AAOpt 2024 talks
Dr Carolyn Majcher chats about GA and posterior uveitis at AAOpt 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Ferrucci summarizes his Vision Expo West presentations and shares clinical pearls for managing retinal cases.
Danica Marrelli, OD, FAAO, AAO Dip, talks OCT and glaucoma
Mark Dunbar, OD, FAAO, gives overview of advancements in GA treatment
Mohammad Rafieetary, OD, FAAO
© 2024 MJH Life Sciences

All rights reserved.